With Resistell’s device physicians get crucial antimicrobial resistance information in hours instead of days. This is confirmed by the results of a study that have been published in a peer-reviewed article in the Nature Communications journal. The publication marks the completion of the company’s technology validation stage and showcases the potential of the Resistell nanomotion technology platform as a diagnostic in the fight against antimicrobial resistance (AMR).
